Publications and Presentations Database

Sort by: Author Title [ Type (Desc)] Year
Journal Article
Guan, Y., Roter, D. L., Erby, L. H., Wolff, J. L., Gitlin, L. N., Roberts, J. S., et al. (2018).  Communication predictors of patient and companion satisfaction with Alzheimer’s disease genetic risk disclosure. Journal of Health Communication. 23(8), 807-814. Abstract
Guan, Y., Roter, D. L., Wolff, J. L., Gitlin, L. N., Christensen, K. D., Roberts, J. S., et al. (2018).  The impact of genetic counselors’ use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer’s disease. Patient Education and Counseling. 101(5), 817-823. Abstract
Guan, Y., Roter, D. L., Wolff, J. L., Gitlin, L. N., Christensen, K. D., Roberts, J. S., et al. (2017).  The impact of genetic counselors’ use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer’s disease. . Patient Education & Counseling. Abstract
Roberts, J. S., Robinson, J. O., Diamond, P. M., Bharadwaj, A., Christensen, K. D., Lee, K. B., et al. (2018).  Patient understanding of, satisfaction with, and perceived utility of whole genome sequencing: Findings from the MedSeq Project. Genetics in Medicine. Abstract
Roberts, J. S., Christensen, K. D., & Green, R. C. (2011).  Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics. Clinical genetics. Abstract
Conference Presentation
Hipps, Y., Roberts, J. S., & Green, R. C. (2002).  African Americans and Whites differ in their interest in predictive testing for Alzheimer’s disease.
Roberts, J. S., Welsh-Bohmer, K., Green, R. C., & Karlawish, J. (2017).  Assessing the impact of disclosing amyloid imaging results to cognitively normal older adults: The REVEAL-SCAN study.
Roberts, J. S., Akinleye, D., Hipps, Y. G., & Green, R. C. (2005).  Beliefs about prevention and treatment of Alzheimer's disease among African Americans.
Roberts, J. S., Uhlmann, W. R., Petersen, R., Karlawish, J., & Green, R. C. (2009).  Clinical practices regarding Mild Cognitive Impairment (MCI) among neurology service providers.
Szymaniak, J. M., Christensen, K. D., Uhlmann, W. R., Green, R. C., & Roberts, J. S. (2009).  A Condensed Genetic Counseling Approach for Alzheimer's Diseases Susceptibility Testing: What is the Psychological Impact? .
Green, R. C., Lingler, J., Karlawish, J., & Roberts, J. S. (2012).  Disclosing risk information to individuals at imminent risk of Alzheimer's disease.
Le, L. Q., Bartnik, N. J., Christensen, K. D., Uhlmann, W. R., Karlawish, J., Obisesan, T., et al. (2016).  Educating Patients and Care Partners about Mild Cognitive Impairment, APOE, and Alzheimer’s Disease: Findings from the REVEAL Study.
Roberts, J. S., Gordon, E., & Green, R. C. (2011).  Empirical research to inform practice and policy in personal genomics.
Roberts, J. S., & Green, R. C. (2005).  Genetic research in dementia: Risk evaluation and education for Alzheimer’s disease.
Roberts, J. S., Green, R. C., Relkin, N., Whitehouse, P., Brown, T., Barber, M., et al. (2002).  Genetic susceptibility testing for adult children of patients with Alzheimer’s disease: Participants’ self-reports on the impact of risk assessment.
Christensen, K. D., Roberts, J. S., & Green, R. C. (2009).  Genetic Susceptibility Testing for Individuals at Risk for Alzheimer's Disease: Findings from the REVEAL Study.
Roberts, J. S., Zick, C., Matthews, C., & Green, R. C. (2004).  Genetic testing for Alzheimer’s disease and its impact on insurance behavior.
Roberts, J. S., Green, R. C., Nelkin, N., Whitehouse, P., Brown, T., Barber, M., et al. (2003).  How do participants rate the impact of genetic susceptibility testing for Alzheimer’s disease?.
Roberts, J. S., Lock, M., Prest, J., Barber, M., Whitehouse, P., LaRusse, S., et al. (2004).  How does genetic testing affect anxiety about developing Alzheimer’s disease? .
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Bhatt, D. L., et al. (2010).  How does pleiotropic information affect health behavior changes? Initial results from the REVEAL Study, a randomized trial of genetic testing for Alzheimer’s disease.
Green, R. C., Roberts, J. S., Brown, T. C., Whitehouse, P. J., Barber, M., Relkin, N. R., et al. (2002).  How many adult children of patients with Alzheimer’s disease will choose genetic susceptibility testing with APOE genotyping?.
Christensen, K. D., Roberts, J. S., Royal, C. D. M., Cupples, L. A., Whitehouse, P. J., Relkin, N. R., et al. (2008).  The Impact of an Education and Risk Evaluation Protocol on Perceived Benefits, Risks and Limitations of Genetic Susceptibility Testing for Alzheimer's Disease.
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Bhatt, D. L., et al. (2009).  The Impact of Pleiotropic Information about Cardiovascular Disease Risk on Health Behavior Changes among People Seeking Genetic Susceptibility Testing for Alzheimer’s Disease: Initial Results from a Randomized Trial.
Christensen, K. D., Roberts, J. S., Royal, C. D. M., Fasaye, G., Obisean, T., Cupples, L. A., et al. (2007).  Incorporating Ethnicity into Genetic Risk Assessment for Alzheimer's Disease: The REVEAL Study Experience.
LaRusse, S., Katzen, H., Brown, T., Barber, M., Whitehouse, P. J., Green, R. C., et al. (2002).  Participant recall of their own apolipoprotein E (APOE) genotype and risk estimate after six weeks: Results from the REVEAL Study.